STXS Stereotaxis Inc

1,718

$1.77

$0.12

(7.27%)

Today

Watchers	1,718
52-Wk Low	$1.33
52-Wk High	$2.75

Market Cap	$143.17M
Volume (M)	218,486.00
52-Wk High	$2.75
52-Wk Low	$1.33

Fundamentals

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease PatientsGlobe Newswire • 5 days ago

LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health...

Share to Feed

Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare ConferenceGlobe Newswire • 13 days ago

ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...

Stereotaxis Reports 2023 Third Quarter Financial ResultsGlobe Newswire • 24 days ago

ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...

Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United StatesGlobe Newswire • about 1 month ago

ST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...

Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023Globe Newswire • about 2 months ago

ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic NavigationGlobe Newswire • about 2 months ago

ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic TechnologyGlobe Newswire • 3 months ago

ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...

Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia TreatmentGlobe Newswire • 3 months ago

ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the first ...

Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm SymposiumGlobe Newswire • 4 months ago

ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...

Stereotaxis Reports 2023 Second Quarter Financial ResultsGlobe Newswire • 4 months ago

ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30, 2023. Stereotaxis delivered 28% revenue growth in the ...